このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

低流量および高流量麻酔が頭蓋内圧に及ぼす影響

2026年11月9日 更新者:Yasin Karabacak、Bursa City Hospital

高流量麻酔と低流量麻酔が腹腔鏡下子宮摘出術中の視神経鞘径および脳酸素化に及ぼす比較効果

This prospective randomized study was conducted to evaluate the effects of low-flow and high-flow anesthesia on intracranial dynamics and cerebral oxygenation in patients undergoing laparoscopic hysterectomy in the Trendelenburg position. Intracranial pressure was assessed noninvasively using optic nerve sheath diameter (ONSD), and cerebral oxygenation was monitored using near-infrared spectroscopy (NIRS). Changes in these parameters were assessed under standardized pneumoperitoneum and positioning conditions, and comparisons between anesthesia flow groups were performed according to the predefined study protocol.

調査の概要

詳細な説明

Laparoscopic surgical procedures commonly involve the establishment of pneumoperitoneum (PP) and the application of the Trendelenburg position (TP) to optimize surgical exposure. These interventions are known to increase intra-abdominal pressure and may influence venous return, intrathoracic pressure, and cerebral hemodynamics. The combined use of pneumoperitoneum and Trendelenburg positioning is considered to have the potential to increase intracranial pressure (ICP). Therefore, the intraoperative assessment of intracranial dynamics is of clinical importance.

Optic nerve sheath diameter (ONSD) measurement is a noninvasive, reproducible, and bedside-applicable method used to assess changes in intracranial pressure. ONSD is considered to correlate with ICP alterations. Cerebral oxygenation can be evaluated using near-infrared spectroscopy (NIRS), a noninvasive technique that enables continuous monitoring of cerebral tissue oxygenation.

Low-flow anesthesia is based on the reduction of fresh gas flow rates and offers several advantages, including decreased anesthetic gas consumption, preservation of heat and humidity in the respiratory tract, and reduced environmental impact. However, data regarding the effects of low-flow anesthesia on cerebral physiology and intracranial dynamics remain limited. In surgical settings where pneumoperitoneum and Trendelenburg positioning are applied, evaluating the impact of different fresh gas flow rates on intracranial pressure and cerebral oxygenation is particularly important.

This prospective, randomized study was conducted in patients scheduled for elective laparoscopic hysterectomy at Bursa City Hospital. Patients aged between 18 and 75 years with an American Society of Anesthesiologists (ASA) physical status of I-II were included. Patients meeting predefined exclusion criteria were not enrolled in the study. Written informed consent was obtained from all participants prior to inclusion.

Patients were randomized into two groups using the closed-envelope method to receive either low-flow or high-flow anesthesia. Standard monitoring, including electrocardiography, noninvasive blood pressure, peripheral oxygen saturation, and NIRS monitoring, was applied to all patients. General anesthesia induction and maintenance were performed according to standardized protocols. Mechanical ventilation was provided in volume-controlled mode, and ventilator parameters were maintained within standard ranges.

Pneumoperitoneum was established using carbon dioxide (CO₂) insufflation at a predefined pressure range and was maintained throughout the surgical procedure. Following the establishment of pneumoperitoneum, patients were placed in the Trendelenburg position at a predefined angle, which was maintained during the operation.

Optic nerve sheath diameter measurements were performed using ultrasonography with minimal pressure applied to the globe. Measurements were obtained at predefined time points. Cerebral oxygenation was continuously monitored using NIRS throughout the intraoperative period. In addition, hemodynamic and respiratory parameters, including heart rate, arterial blood pressure, end-tidal carbon dioxide (EtCO₂), and ventilatory variables, were recorded.

Within the scope of this study, the effects of low-flow and high-flow anesthesia on intracranial dynamics and cerebral oxygenation were planned to be comparatively evaluated, and the study was conducted in accordance with the predefined protocol.

研究の種類

介入

入学 (実際)

64

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~75年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

女性

説明

Inclusion Criteria

  • Female patients aged 18-75 years
  • Scheduled for elective laparoscopic hysterectomy
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Ability to provide written informed consent

Exclusion Criteria

  • Septicemia
  • Risk of malignant hyperthermia
  • Uncontrolled diabetes mellitus
  • Chronic alcohol use
  • Prolonged fasting
  • Body mass index (BMI) > 40 kg/m²
  • Intracranial space-occupying lesions (e.g., tumors, metastases, abscesses, hematomas, aneurysms)
  • History of head trauma or cerebrovascular stroke within the preceding six months
  • Known heart failure
  • Diagnosis of glaucoma
  • Prior carotid surgery or carotid artery stenosis
  • ASA physical status ≥ III
  • Requirement for massive blood transfusion
  • Conversion from volume-controlled to pressure-controlled mechanical ventilation during surgery
  • Intraoperative conversion to open surgery
  • Patient refusal to participate

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:LOW-FLOW ANESTHESİA

Patients in this group received general anesthesia with sevoflurane. Fresh gas flow was initially set at 3 L/min until a minimum alveolar concentration (MAC) of 1.0 was achieved, after which it was reduced to 1 L/min and maintained throughout the procedure.

Patients assigned to the low-flow anesthesia group initially received a fresh gas flow of 3 L/min with a mixture of 50% oxygen and 50% air until a minimum alveolar concentration (MAC) of 1.0 was achieved. Subsequently, the fresh gas flow was reduced to 1 L/min, with oxygen and air concentrations maintained at 50-60% and 40-50%, respectively. Anesthesia was maintained with sevoflurane and a continuous remifentanil infusion.

実験的:HIGH-FLOW ANESTESIA

Patients assigned to the high-flow anesthesia group received general anesthesia with sevoflurane using a fresh gas flow rate of 3 L/min throughout the procedure. A gas mixture consisting of 50% oxygen and 50% air was administered, with a target minimum alveolar concentration (MAC) of 1.0. Remifentanil was administered as a continuous intravenous infusion at 0.05-0.1 μg/kg/min

Patients assigned to the high-flow anesthesia group received a fresh gas flow of 3 L/min throughout the procedure, using a mixture of 50% oxygen and 50% air. Anesthesia was maintained with sevoflurane at a target minimum alveolar concentration (MAC) of 1.0, together with a continuous remifentanil infusion.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Optic Nerve Sheath Diameter
時間枠:1-4 hour

To determine the differences between the two groups of trendelenburg and pneumoperitoneum, which increase intracranial pressure.

1-4 hour

二次結果の測定

結果測定
メジャーの説明
時間枠
Cerebral Oxygenation
時間枠:1-4 hour

To determine the effects of low-flow and high-flow anesthesia on cerebral oxygenation in conditions that increase intracranial pressure.

1-4 hour

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年1月1日

一次修了 (実際)

2024年12月1日

研究の完了 (実際)

2025年6月1日

試験登録日

最初に提出

2026年3月25日

QC基準を満たした最初の提出物

2026年4月5日

最初の投稿 (実際)

2026年4月7日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月12日

QC基準を満たした最後の更新が送信されました

2026年11月9日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2023-17/2

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

Protecting patient privacy and ensuring the security of patient personal information is paramount. However, in our study, some data can be shared without compromising patient safety.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する